UBA1 and VEXAS syndrome: Whereas monogenic autoinflammatory conditions have been classically identified through a "top-down" approach, VEXAS syndrome was firstly identified through a whole genome sequencing of more than 2000 patients, during which a mutation in the methionine-41 residue of ubiquitin-activating enzyme 1 (UBA1) was found [3].